Citation

Witzel JG, Gubka U, Weisser H, Bogerts B. Int. J. Prison Health 2008; 4(2): 96-103.

Affiliation

Central State Forensic Psychiatric Hospital of Saxony-Anhalt, Uchtspringe, Germany. j.witzel@salus-lsa.de

Copyright

(Copyright © 2008, Emerald Group)

DOI

10.1080/17449200802038165

PMID

18464063

Abstract

In past years, Zuclopenthixolacetate as well as Flupentixoldecanoate have each proven to be reliable and efficient in the treatment of schizophrenic psychoses. In a specially implemented psychiatric treatment unit (PTU) we administered a high-dose depot neuroleptic combination therapy initially consisting of both substances to seriously ill schizophrenic prisoners who exhibited highly aggressive behaviour (N=20). We initially used both antipsychotics at the same time as a simple regimen in order to restore the prisoners' health to enable them to return to their home prisons. A single coercive intervention was performed in 14 out of 20 prisoners which was followed by a second one in two cases according to Article 101 of the German Code of Criminal Procedure. On average, prisoners needed a treatment course of 30.4 days. Within this time PANSS global scores were reduced by approximately 40%. Side effects occurring as a consequence of neuroleptic treatment were negligible and could be dealt with.

Language: en